Law Practice
May 30, 2008
Lead Counsel in Bextra, Celebrex Trials Jumps In House to Pfizer
The lead defense attorney for Pfizer Inc. in the company's product liability litigation over the painkillers Bextra and Celebrex has signed on as the pharmaceutical giant's general counsel, Pfizer announced Wednesday.
Daily Journal Staff Writer
This article appears on Page 1
The lead defense attorney for Pfizer Inc. in the company's product liability litigation over the painkillers Bextra and Celebrex has signed on as the pharmaceutical giant's general counsel, Pfizer announced Wednesday.
Amy W. Schulman, 47, a partner in DLA Piper's New York office, starts her new posi...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In